Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elucidation of gene function using C-5 propyne antisense oligonucleotides

W M Flanagan1, L L Su, R W Wagner

  • 1Gilead Sciences, Foster City, CA 94404, USA. michael_flanagan@gilead.com

Nature Biotechnology
|September 1, 1996
PubMed
Summary

Modified antisense oligonucleotides (ONs) effectively inhibit cell cycle genes in breast cancer cells. This demonstrates their utility for studying gene function and reveals potential cancer cell adaptability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of area deprivation index in health care disruptions among cancer survivors during the SARS-CoV-2 pandemic.

Public health·2024
Same author

[Correlations between the average Young's modulus and histopathological characteristics of papillary thyroid carcinoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2024
Same author

[Effects of microRNA-34a on regulating silent information regulator 1 and influence of the factor on myocardial damage of rats with severe burns at early stage].

Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns·2018
Same author

The OncoSim model: development and use for better decision-making in Canadian cancer control.

Current oncology (Toronto, Ont.)·2017
Same author

[Effects of activating silent information regulator 1 on early kidney damage in rats with severe burn].

Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns·2017
Same author

[Effects of hypoxia on the phenotype transformation of human dermal fibroblasts to myofibroblasts and the mechanism].

Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns·2017

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Understanding gene function is crucial for developing disease cures.
  • Aberrant expression of cell cycle proteins like p34cdc2 kinase and cyclin B1 is common in breast cancer.
  • A simple and reproducible method is needed to elucidate gene function.

Purpose of the Study:

  • To evaluate the efficacy of C-5 propyne pyrimidine modified phosphorothioate antisense oligonucleotides (ONs) in inhibiting p34cdc2 kinase and cyclin B1.
  • To assess the specificity and utility of these modified ONs as biological tools.
  • To investigate the impact of inhibiting p34cdc2 kinase on cell cycle progression in normal and breast cancer cells.

Main Methods:

  • Utilized C-5 propyne pyrimidine modified phosphorothioate antisense oligonucleotides (ONs) targeting p34cdc2 kinase and cyclin B1.

Related Experiment Videos

  • Administered ONs to normal and breast cancer cells in dose-dependent and sequence-specific manner.
  • Analyzed cell cycle progression using flow cytometry after ON treatment.

    • Main Results:

    • Achieved dose-dependent, sequence-specific, and gene-specific inhibition of p34cdc2 kinase and cyclin B1 at nanomolar concentrations.
    • Confirmed that precise RNA binding of ONs was essential for antisense activity; mismatches abolished it.
    • Observed significant G2/M phase cell cycle arrest in normal cells upon p34cdc2 kinase inhibition, with minimal effect on breast cancer cells.

    Conclusions:

    • C-5 propyne modified antisense ONs are potent and specific biological tools for gene function studies.
    • Breast cancer cells may exhibit functional redundancy in cell cycle protein pathways, contributing to resistance.
    • These findings highlight the potential of antisense technology in cancer research and therapeutic development.